Back to mobile site

BNP Paribas Exane Downgrades Medical Properties Trust (MPT) to Neutral

November 3, 2026 2:29 AM EST Send to a Friend
BNP Paribas Exane analyst Nate Crossett downgraded Medical Properties Trust (NYSE: MPT) from Outperform to Neutral with a price target ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login